A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study is to assess the plasma concentration-time profile of voriconazole in adults
receiving 7-day intravenous treatment and 6.5-day oral treatment. This study is also to
assess the safety profile of voriconazole during the treatment period.